Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.

Many TRIM proteins are responsive to interferon (IFN), with some functioning as downstream effectors of IFN in innate immune responses to retroviruses and other viruses. Members with anti-HIV ...